NCT03241043View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Liver Transplantation
Interventions
DRUG

Treatment 2 weeks Envarsus followed by 2 weeks Advagraf

DRUG

Treatment 2 weeks Advagraf followed by 2 weeks Envarsus

Trial Locations (1)

Unknown

University Hospital Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT03241043 - Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients | Biotech Hunter | Biotech Hunter